Tomorrow morning (July 21, 2026) in Boston, Alpha Tau Medical Ltd. (Nasdaq: DRTS) will step to the podium at a major head and neck cancer conference to answer a question that has quietly frustrated oncologists: can you actually make Keytruda work better with radiation, or does the radiation cancel out the drug?
https://www.bioreview.com/alpha-taus-head-and...cer-drugs/